Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5

Infection and Immunity

Volumn 66, Issue 9, 1998, Pages 4244-4253

  Burns, Acy M ^a   Hull, Sheila I ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; O ANTIGEN; PLASMID VECTOR;

ARTICLE; BACTERIOLYSIS; CELL VIABILITY; CHROMOSOME MUTATION; DELETION MUTANT; ESCHERICHIA COLI; GENE MUTATION; GENETIC MANIPULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; URINARY TRACT INFECTION;

ESCHERICHIA COLI;

EID: 3543022057     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/.66.9.4244-4253.1998     Document Type: Article

References (64)

1. Achtman, M., A. Mercer, B. Kusecek, A. Pohl, M. Heuzenroeder, W. Aaronson, A. Sutton, and R. P. Silver. 1983. Six widespread bacterial clones among Escherichia coli K1 isolates. Infect. Immun. 39:315-335.
2. Allen, P. M., I. Roberts, G. J. Boulnois, J. R. Saunders, and C. A. Hart. 1987. Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1. Infect. Immun. 40:359-368.
3. Batchelor, R., G. E. Haraguchi, R. A. Hull, and S. I. Hull. 1991. Regulation by a novel protein of the bimodal distribution of lipopolysaccharide in the outer membrane of Escherichia coli. J. Bacteriol. 173:5699-5704.
4. Batchelor, R. A. 1992. Ph.D. thesis. Baylor College of Medicine. Houston, Tex.
5. Batchelor, R. A., P. Alfina, E. Biffali, S. I. Hull, and R. Hull. 1992. Nucleotide sequences of the genes regulating O-polysaccharide antigen chain length (rol) from Escherichia coli and Salmonella typhimurium: protein homology and functional complementation. J. Bacteriol. 174:5228-5236.
6. Boulnois, G. J., and I. S. Roberts. 1990. Genetics of capsular polysaccharide production in bacteria. Curr. Top. Microbiol. Immunol. 150:1-18.
7. Chang, A. C. Y., and S. N. Cohen. 1978. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from P15A cryptic miniplasmid. J. Bacteriol. 134:1141-1156.
8. Cross, A. S. 1990. The biological significance of bacterial encapsulation. Curr. Top. Microbiol. Immunol. 150:87-98.
9. Cross, A. S., P. Gemski, J. C. Sadoff, F. Ørskov, and I. Ørskov. 1984. The importance of the K1 capsule in invasive infections caused by Escherichia coli. J. Infect. Dis. 149:184-193.
10. Cross, A. S., K. S. Kim, D. C. Wright, J. C. Sadoff, and P. Gemski. 1986. Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli. J. Infect. Dis. 154:497-503.
11. Curtiss, R. 1969. Bacterial conjugation. Annu. Rev. Microbiol. 23:69-136.
12. Curtiss, R., III, L. J. Charamella, C. M. Berg, and P. E. Harris. 1965. Kinetic and genetic analysis of D-cycloserine inhibition and resistance in Escherichia coli. J. Bacteriol. 90:1238-1250.
13. Davis, B. D., and E. S. Mingioli. 1950. Mutants of Escherichia coli requiring methionine or vitamin B12. J. Bacteriol. 60:17-28.
14. Devine, D. A., and A. P. Roberts. 1994. K1, K5 and O antigens of Escherichia coli in relation to serum killing via the classical and alternative complement pathways. J. Med. Microbiol. 41:139-144.
15. Erbing, C., S. Svensson, and S. Hammarstrom. 1975. Structural studies on the O-specific side-chains of the cell wall lipopolysaccharide from E. coli O75. Carbohydr. Res. 44:259-265.
16. Gemski, P., A. S. Cross, and J. C. Sadoff. 1980. K1 antigen-associated resistance to the bactericidal activity of serum. FEMS Microbiol. Lett. 9:193-197.
17. Grossman, N., K. A. Joiner, M. M. Frank, and L. Leive. 1986. C3b binding but not its breakdown is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonella. J. Immunol. 136:2208-2212.
18. Grossman, N., M. A. Schmetz, J. Foulds, E. Klima, V. Jimenez-Lucho, L. Leive, and K. A. Joiner. 1987. Lipopolysaccharide size and distribution determine serum resistance in Salmonella montevideo. J. Bacteriol. 169:856- 863.
19. Hagberg, L., R. Hull, S. Hull, S. Falkow, R. Freter, and C. Svanborg Edén. 1983. Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect. Immun. 40:265-272.
20. Haraguchi, G. E., Z. Ulrich, B. Jann, K. Jann, R. A. Hull, and S. Hull. 1991. Genetic characterization of the O4 polysaccharide gene cluster from Escherichia coli. Microb. Pathog. 10:351-361.
21. Hitchcock, P. J., and T. M. Brown. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
22. Hull, S. I., K. L. Yoas, and R. A. Hull. Unpublished data.
23. Jann, B., K. Reske, and K. Jann. 1975. Heterogeneity of lipopolysaccharides. Analysis of chain length by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Eur. J. Biochem. 60:239-246.
24. Jann, B., A. S. Shashkov, H. Kochanowski, and K. Jann. 1993. Structural comparison of the O4 specific polysaccharides from E. coli O4:K6 and E. coli O4:K52. Carbohydr. Res. 248:241-250.
25. Jann, K., and B. Jann. 1987. Polysaccharide antigens of Escherichia coli. Rev. Infect. Dis. 9:516-526.
26. Jiang, X.-M., B. Neal, F. Santiago, S. J. Lee, L. K. Romana, and P. R. Reeves. 1991. Structure and sequence of the rfb (O antigen) gene cluster of Salmonella serovar typhimurium (strain LT2). Mol. Microbiol. 5:2285-2292.
27. Joiner, K. A., N. Grossman, M. Schmetz, and L. Leive. 1986. C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J. Immunol. 136:710-715.
28. Joiner, K. A. 1988. Complement evasion by bacteria and parasites. Annu. Rev. Microbiol. 42:201-230.
29. Joiner, K. A. 1986. Role of complement in infectious diseases, p. 183-195. In G. D. Ross (ed.), Immunobiology of the complement system: an introduction for research and clinical medicine. Academic Press, Inc., Orlando, Fla.
30. Joiner, K. A., C. H. Hammer, E. J. Brown, R. J. Cole, and M. M. Frank. 1982. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death. J. Exp. Med. 155:797-804.
31. . Kushner, S. 1987. Useful host strains and techniques for recombinant DNA experiments, p. 1190-1219. In F. C. Neidhardt, J. L. Ingraham. K. B. Low, B. Magasanik, M. Schaechter, and H. E. Umharger (ed.), Escherichia coli and Salmonella typhimurium: cellular and molecular biology. American Society for Microbiology, Washington, D.C.
32. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
33. Lesse, A. J., A. A. Campagnari, W. E. Bittner, and M. A. Apicella. 1990. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J. Immunol. Methods 126:109-117.
34. Leying, H., S. Suerbaum, H.-P. Kroll, D. Stahl, and W. Opferkuch. 1990. The capsular polysaccharide is a major determinant of serum resistance in K-1positive blood culture isolates of Escherichia coli. Infect. Immun. 58:222-227.
35. Lukomski, S., R. A. Hull, and S. I. Hull. 1996. Identification of the O antigen polymerase (rfc) gene in Escherichia coli O4 hy insertional mutagenesis using a nonpolar chloramphenicol resistance cassette. J. Bacteriol. 178:240-247.
36. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
37. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170:2575-2583.
38. Miller, V. L., and J. J. Mekalanos. 1984. Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR. Proc. Natl. Acad. Sci. USA 81:3471-3475.
39. Navia, J. L., J. Riesenfeld, W. R. Vann, U. Lindahl, and L. Roden. 1983. Assay of N-acetylheparosan deacetylase with a capsular polysaccharide from Escherichia coli K5 as substrate. Anal. Biochem. 135:134-140.
40. Nikaido, H., and M. Vaara. 1985. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49:1-32.
41. Ørskov, I., and F. Ørskov. 1985. Escherichia coli and extra-intestinal infections. J. Hyg. Camb. 95:551-575.
42. Ørskov, I., F. Ørskov, B. Jann, and K. Jann. 1977. Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol. Rev. 41:667-710.
43. Palva, E. T., and P. H. Mäkelä. 1980. Lipopolysaccharide heterogeneity in Salmonella typhimurium analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Eur. J. Biochem. 107:137-143.
44. Petit, C., G. Rigg, C. Pazzani, A. Smith, V. Sieberth, M. Stevens, G. J. Boulnois, K. Jann, and I. S. Roberts. 1985. Analysis of region 2 of the Escherichia coli K5 capsule gene cluster: a region encoding proteins for the biosynthesis of the K5 polysaccharide. Mol. Microbiol. 17:611-620.
45. Petit, C., G. P. Rigg, C. Pazzani, A. Smith, V. Sieberth, M. Stevens, G. Boulnois, K. Jann, and I. S. Roberts. 1995. Region 2 of the Escherichia coli K5 capsule gene cluster encoding proteins for the biosynthesis of the K5 polysaccharide. Mol. Microbiol. 17:611-620.
46. Pluschke, G., J. Mayden, M. Achtman, and R. P. Levine. 1983. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement killing. Infect. Immun. 42:907-913.
47. Russo, T. A., and G. Singh. 1993. An extraintestinal, pathogenic isolate of Escherichia coli (O4/K54/H5) can produce a group 1 capsule which is divergently regulated from its constitutively produced group 2, K54 capsular polysaccharide. J. Bacteriol. 175:7617-7623.
48. Russo, T. A., G. Sharma, C. R. Brown, and A. A. Campagnari, 1995. Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo. Infect. Immun. 63:1263-1269.
49. Schagger, H., and G. von Jagow. 1987. Tricine-sodium dodecyl sulfatepolyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368-379.
50. Schnaitman, C. A., and J. D. Klena. 1993. Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol. Rev. 57:655-682.
51. Schweizer, H. P. 1990. The pUC18CM plasmids: a chloramphenicol resistance gene cassette for site-directed insertion and deletion mutagenesis in Escherichia coli. BioFeedback 8:614-616.
52. Sieberth, V., G. P. Rigg, I. S. Roberts, and K. Jann. 1995. Expression and characterization of UDPGlc dehydrogenase (KfiD), which is encoded in type-specific region 2 of the Escherichia coli K5 capsule genes. J. Bacteriol. 177:4562-4565.
53. Simon, R., U. Priefer, and A. Pühler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Bio/Technology 1:784-791.
54. Stevens, P., S. N.-Y. Huang, W. D. Welch, and W. L. Welch. 1978. Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity. J. Immunol. 121:1216-1217.
55. Svanborg-Edén, C., L. Hagberg, R. Hull, S. Hull, K.-E. Magnusson, and L. Ohman. 1987. Bacterial virulence versus host resistance in the urinary tracts of mice. Infect. Immun. 55:1224-1232.
56. Svanborg-Edén, C., L. Hagberg, D. Briles, J. McGhee, and S. Michalek. 1985. Susceptibility to Escherichia coli urinary tract infection and LPS responsiveness, p. 385-391. In E. Skamene (ed.). Genetic control of host sistance to infection and malignancy. Alan R. Liss, Inc., New York, N.Y.
57. Svanborg-Edén, C., L. Hagberg, L. A. Hanson, T. Korhonen, H. Leffler, and S. Olling. 1983. Target cell specificity of wild type E. coli and mutants and clones with genetically defined adhesins. Prog. Food Nutr. Sci. 7:75-89.
58. Taylor, P. W. 1983. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol. Rev. 47:46-83.
59. Taylor, P. W., P. Messner, and R. Parton. 1981. Effect of the growth environment on cell envelope components of Escherichia coli in relation to sensitivity to human serum. J. Med. Microbiol. 14:9-19.
60. Taylor, P. W. 1985. Measurement of the bactericidal activity of serum, p. 445-457. In M. Sussman (ed.), The virulence of Escherichia coli. Academic Press Ltd., London, England.
61. . Timmis, K. N., G. J. Boulnois, D. Bitter-Suermann, and F. C. Cabello. 1985. Surface components of Escherichia coli that mediate resistance to the bactericidal activities of serum and phagocytes. Curr. Top. Microbiol. Immunol. 118:197-218.
62. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharide in polyacrylamide gels. Anal. Biochem. 119:115-119.
63. Valvano, M. A. 1992. Pathogenicity and molecular genetics of O-specific side-chain lipopolysaccharides of Escherichia coli. Can. J. Microbiol. 38:711-719.
64. Vermeulen, C., A. Cross, W. R. Byrne, and W. Zollinger. 1988. Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli. Infect. Immun. 56:2723-2730.